Dublin, July 24, 2017 -- The "Global Topical Drug Delivery Market - Trends and Forecast to 2024" report has been added to Research and Markets' offering.
Global Topical Drug Delivery Market is Expected to Reach USD 194.2 Billion by 2024, at a CAGR 9.3% During the Forecast Period of 2017 to 2024
Topical drug delivery involves the introduction of a medication to the body surface such as skin or mucous membrane or to the circulatory system by periodic transdermal drug delivery for the treatment of diseases. It is considered as key route for local and systemic treatment. Drugs delivered through this route of administration penetrate deeply into the skin and are better absorbed. Topical drugs such as sunscreens and astringents are used for prophylaxis.
They are used in the treatment of skin conditions such as bacterial, fungal, and viral infections; inflammation; pruritus; corns; warts; and other dermatologic conditions. Also products such as transdermal patches provide systemic drug delivery non-invasively. Topical drug delivery includes liquid, semi-solid, solid, and transdermal patches and gels.
Key Topics Covered:
1 Introduction
1.1. Overview of the Global Topical Drug Delivery Market
1.2. Market Segmentation & Coverage
1.2.1. Currency and Pricing
1.2.2. Limitation
1.2.3. Stakeholders
2 Research Methodology
2.1. Key Takeaways
2.2. Arriving at the Global Topical Drug Delivery Market Size
2.2.1. Market Crackdown Approach
2.2.2. Company Revenue and Market Share Analysis
2.2.3. Data Triangulation
2.2.4. Key Data Points from Primary Sources
2.2.5. Product Pipeline Analysis
2.2.6. Porter's Five Forces Matrix
2.4. Global Topical Drug Delivery Market: Research Snapshot
2.5. Assumptions
3 Market Landscape Summary
4 Premium Insights
4.1. Overview
4.2. Global Topical Drug Delivery Market: Key Primary Insights
4.3. Market Overview
4.3.1. Drivers
4.3.1.1. Rising Prevalence of Chronic Disease Such as Diabetes
4.3.1.2. Growth in Transdermal Technology
4.3.1.3. Innovation and Development of New Drug Types
4.3.1.4. Better Healthcare Spending in South Asia and Africa
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Threats
4.4. Key Market Trends and Upcoming Technologies
5 Executive Summary
6 Topical Drug Delivery Market, by Product Type
6.1. Overview
6.2. Topical Drug Delivery, by Product Type
6.2.1. Transdermal Drug Delivery Devices, by Product Type
6.2.1.1. Transdermal Patches
6.2.1.2. Transdermal Gels
6.2.2. Topical Drug Delivery Formulations, by Form
6.2.2.1. Liquid Topical Drug Delivery Formulations, by Type
6.2.2.1.1. Solutions
6.2.2.1.2. Suspensions
6.2.2.2. Semi-Solid Topical Drug Delivery Formulations, by Type
6.2.2.2.1. Gels
6.2.2.2.2. Creams
6.2.2.2.3. Ointments
6.2.2.2.4. Pastes
6.2.2.2.5. Lotions
6.2.2.3. Solid Topical Drug Delivery Formulations, by Type
6.2.2.3.1. Suppositories
6.2.2.3.2. Powders
7 Topical Drug Delivery Market, by End-User
7.1. Overview
7.2. Hospitals
7.3. Home Healthcare
7.4. Clinics
7.5. Diagnostic Centers
7.6. Others
8 Topical Drug Delivery Market, by Distribution Channel
8.1. Overview
8.2. Hospital Pharmacies
8.3. Pharmacy Stores
8.4. Direct Tenders
8.5. Online Pharmacy
9 Topical Drug Delivery Market, by Geography
10 Topical Drug Delivery Market: Competitive Landscape
11 Topical Drug Delivery Market, Company Profiles
- 3M Drug Delivery Systems
- Antares Pharma Inc.
- Biofarmitalia S.R.L
- Crescita Therapeutics
- Easton Pharmaceuticals Inc.
- Endo Pharmaceuticals Inc.
- Galderma S.A.
- Hisamitsu Pharmaceutical Co. Inc.
- Janssen Pharmaceuticals Inc. (A J&J Company)
- Lohmann Therapie-Systeme AG
- Mylan Pharmaceuticals Inc.
- Nitto Denko Corporation
- Pharmatek Laboratories Inc.
- Prosollus Pharmaceuticals
- Samyang Biopharmaceuticals Corporation
- Sheffield Pharmaceuticals Inc.
- Solvay
- Stiefel Laboratories Inc.
- Tapemark
- Therasolve NV
- Transdermal Technologies Inc.
- Valeant Pharmaceuticals International Inc.
For more information about this report visit https://www.researchandmarkets.com/research/f3cx57/global_topical
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Drug Delivery


South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Italy Fines Apple €98.6 Million Over App Store Dominance
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants 



